Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 335-344

  Sparks, D Larry ^a,c   Kuo, Yu Min ^a   Roher, Alex ^a   Martin, Tim ^b   Lukas, Ronald J ^b  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; EPIBATIDINE; EVANS BLUE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CHOLESTEROL DIET; CONFERENCE PAPER; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; NEUROPIL; NONHUMAN; PARENCHYMA; RABBIT; VASCULAR ENDOTHELIUM;

ANAS; ANIMALIA; BROMUS; LEYMUS MOLLIS MOLLIS; ORYCTOLAGUS CUNICULUS; POA; VERTEBRATA;

EID: 0034098980     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06384.x     Document Type: Conference Paper

References (30)

1. 1. SPARKS, D.L. et al. 1990. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging 11: 601-607.
2. 2. SPARKS, D.L. et al. 1995. Increased density of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J. Neurol. Sci. 131: 162-169.
3. 3. SONEIRA, C.F. & T.M. SCOTT. 1996. Severe cardiovascular disease and Alzheimer's disease: senile plaque formation in cortical areas. Clin. Anat. 9: 118-127.
4. 4. SPARKS, D.L. 1999. Neuropathologic links between Alzheimer's disease and vascular disease. In Alzheimer's Disease and Related Disorders. K. Iqbal, D.F. Swaab, B. Winblad & H.M. Wisniewski, Eds. Vol. 6: 153-163. John Wiley & Sons Ltd. New York.
5. 5. MARTINS, C. et al. 1990. Effect of age and dementia on the prevalence of cardiovascular disease. Age 13: 9-11.
6. 6. SKOOG, I. et al. 1996. 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141-1145.
7. 7. JARVIK, G.P. et al. 1995. Interactions of apolipoprotein E genotype, total cholesterol level, age, sex in prediction of Alzheimer's disease: a case-control study. Neurology 45: 1092-1096.
8. 8. GRANT, W.B. 1997. Dietary links to Alzheimer's disease. Alzheimer's Dis. Rev. 2: 42-55.
9. 9. KALMIJN, S. et al. 1997. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann. Neurol. 42: 776-782.
10. 10. NOTKOLA, I.-L. et al. 1998. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17: 14-20.
11. 11. SPARKS, D.L. et al. 1994. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126: 88-94.
12. 12. SPARKS, D.L. 1996. Intraneuronal β-amyloid immunoreactivity in the CNS. Neurobiol. Aging 17: 291-299.
13. 13. SPARKS, D.L. et al. 1995. Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol. Neurosci. Lett. 187: 142-144.
14. 14. HAAS, U. & D.L. SPARKS. 1996. Cathepsin D: activity and immunocytochemical localization in Alzheimer's disease and aging. Mol. Chem. Neuropathol. 29: 1-14.
15. 15. SPARKS, D.L. 1997. Dietary cholesterol induces Alzheimer-like β-amyloid immunore-activity in rabbit brain. Nutr. Metab. Cardiovasc. Dis. 7: 255-266.
16. 16. STREIT, W.J. & D.L. SPARKS. 1997. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J. Mol. Med. 75: 130-138.
17. 17. DURHAM, R.A. et al. 1998. Effect of age and diet on the expression of beta-amyloid 1-40 and 1-42 in the brains of apolipoprotein-E-deficient mice. Neurobiol. Aging 19: S281.
18. 18. DOPP, J.M. et al. 1994. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J. Neuroimmunol. 54: 129-144.
19. 19. ENGELHARDT, B. et al. 1994. Cell adhesion molecules on vessels during inflammation in the mouse central nervous system. J. Neuroimmunol. 51: 199-208.
20. 20. LUKAS, R.J. 1984. Properties of curaremimetic neurotoxin binding sites in the rat central nervous system. Biochemistry 23: 1152-1160.
21. 3H]acetylcholine binding sites. J. Pharmacol. Exp. Ther. 253: 51-57.
22. 3H]Epibatidine binding to nicotinic cholinergic receptors in brain. Med. Chem. Res. 4: 538-546.
23. 23. KUO, Y.-M. et al. 1998. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain A-beta 1-42 levels. BBRC 252: 711-715.
24. 42 are sequestered by plasma proteins in Alzheimer's disease. BBRC 257: 787-791.
25. 25. WARPMAN, U. & A. NORDBERG. 1995. Epibatidine and ABT 418 reveal selective losses of alpha4 beta2 nicotinic receptors in Alzheimer brains. Neuroreport 6: 2419-2423.
26. 26. HELLSTROM-LINDAHL, E. et al. 1999. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res. Mol. Brain Res. 66: 94-103.
27. 27. MARUTLE, A. et al. 1999. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. J. Neurochem. 72: 1161-1169.
28. 28. KALARIA, R.N. & S.N. KROON, 1992. Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects. Acta Neuropathol. (Berl.) 82: 606-612.
29. 29. KALARIA, R.N. & P. HEDERA, 1995. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6: 477-480.
30. 30. KALARIA, R.N. 1996. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 72: 193-214.